Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
University Hospital, Antwerp
ClinicalTrials.gov Identifier:
NCT01329276
First received: March 30, 2011
Last updated: April 1, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)